30 Million Tuberculosis Patients Screened In Remote Areas: JP Nadda

India is a major manufacturer of anti-TB drugs for the world, having almost an 80 per cent global market share.

Read More
Publication Date: 
17/11/2017
NDTV
Tags:
Tuberculosis (TB), Infectious Diseases, Ministry Of Health And Family Welfare, Health Effects, Health